BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3
BioNTech’s Q3 revenue surged to €1.244 billion, reflecting early COVID-19 vaccine approvals. Net profit rose to €198.1 million, and full-year guidance adjusted downward. read more ​Â
Media
Media
Trump Media Stock Volatile On Election Eve As Polls, Betting Markets Predict Tight White House Race
- by
- November 4, 2024
Trump Media & Technology Group shares are volatile with less than 48 hours to go until Election Day. Here’s a look at what’s going on. read more ​Â
Media
Microsoft, Amazon And Apple All Surpassed Estimates With Their Quarterly Performance, But Only One Stock Ticked Higher
- by
- November 4, 2024
On Thursday, Microsoft Corporation (NASDAQ: MSFT), Amazon.com Inc (NASDAQ: AMNZ) and Apple Inc (NASDAQ: AAPL) issued their September quarter results. read more ​Â
Media
Loews Reports Strong Q3 With 58% Net Income Surge, Backed by CNA Financial And Boardwalk Pipelines
- by
- November 4, 2024
Loews Corp reported strong Q3 earnings with increased net income and revenues. CNA Financial Corp also saw growth, while Boardwalk Pipelines and Loews Hotels improved results. read more ​Â
Media
Analyst Scoreboard: 11 Ratings For Comcast
- by
- November 4, 2024
Latest Ratings for CMCSA Date Firm Action From To Mar 2022 Truist Securities Downgrades Buy Hold Jan 2022 Barclays Maintains Overweight Jan 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for CMCSA View the Latest Analyst Ratings read more ​Â
Media
33 Analysts Assess Okta: What You Need To Know
- by
- November 4, 2024
Latest Ratings for OKTA Date Firm Action From To Mar 2022 Mizuho Upgrades Neutral Buy Mar 2022 Guggenheim Maintains Buy Mar 2022 Needham Maintains Buy View More Analyst Ratings for OKTA View the Latest Analyst Ratings read more ​Â
Media
Demystifying Chart Industries: Insights From 8 Analyst Reviews
- by
- November 4, 2024
Latest Ratings for GTLS Date Firm Action From To Mar 2022 B of A Securities Upgrades Neutral Buy Mar 2022 Barclays Maintains Overweight Feb 2022 Wells Fargo Maintains Overweight View More Analyst Ratings for GTLS View the Latest Analyst Ratings read more ​Â